| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.42 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.4 | 0.05 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |